← Back to Executive Order Summaries

Making America Healthy Again by Empowering Patients With Clear, Accurate, and Actionable Healthcare Pricing Information

Executive Order: 14221
Issued: February 25, 2025
Federal Register Doc. No.: 2025-03440
Federal Register: HTMLPDF

Executive Order 14221 aims to reinvigorate and strengthen healthcare price transparency initiatives first established during President Trump's previous administration. The order characterizes the American healthcare system as having suffered from opaque pricing arrangements that allowed hospitals and insurance companies to operate with 'insufficient accountability,' placing financial burdens on patients, employers, and taxpayers through 'inflated healthcare costs.' The order frames these transparency efforts as a continuation of work begun under Executive Order 13877 (2019), which required hospitals and health plans to publish pricing information, while asserting that enforcement and implementation of these measures stalled during the Biden administration.

The order directs three specific actions to be taken within 90 days by the Secretaries of Treasury, Labor, and Health and Human Services. First, it mandates the disclosure of actual prices for healthcare items and services rather than estimates. Second, it calls for updated guidance or regulatory action to ensure pricing information is standardized and easily comparable across hospitals and health plans. Third, it requires guidance or regulatory action to update enforcement policies aimed at ensuring compliance with transparent reporting requirements. The order cites economic analyses suggesting that full implementation of the original transparency regulations could generate up to $80 billion in healthcare savings by 2025 and potentially reduce employer healthcare costs by 27 percent across 500 common services.

Implementation responsibility falls primarily to the three cabinet secretaries named above, who are directed to 'take all necessary and appropriate action' to rapidly implement and enforce the healthcare price transparency regulations issued pursuant to the 2019 executive order. The order frames these transparency measures as creating a 'more competitive, innovative, affordable, and higher quality healthcare system' by empowering patients with information needed for 'well-informed healthcare decisions.' While not specifying enforcement mechanisms in detail, the order suggests a significant increase in enforcement compared to what it characterizes as insufficient accountability measures in the recent past. The order includes standard provisions clarifying that it does not impair existing authorities, must be implemented consistent with applicable law, and creates no enforceable rights.